AVENUE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AVENUE THERAPEUTICS, INC. (ATXI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-30
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-12-31 was 0.00 shares.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-09-30 was 234.00K shares.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2024-06-30 was 0.00 shares.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 234.00K shares, a 941.20% increase from fiscal 2023.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 22.47K shares.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 0.00 shares, a 100.00% decline from fiscal 2017.
- AVENUE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 20.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-30 | 234.00K shares derived: sum of 3 quarters · filed 2026-03-30 | 234.00K shares derived: sum of 4 quarters · filed 2026-03-30 | ||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 234.00K shares derived: sum of 2 quarters · filed 2026-03-30 | 234.00K shares derived: sum of 3 quarters · filed 2026-03-30 | 234.00K shares 10-K · filed 2026-03-30 | ||
| 2024-09-30 | 234.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 234.00K shares derived: sum of 2 quarters · filed 2024-11-14 | 234.00K shares 10-Q · filed 2024-11-14 | -1.68B shares derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 0.00 shares 10-Q · filed 2024-08-09 | -1.68B shares derived: sum of 3 quarters · filed 2025-03-31 | -1.68B shares derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | -1.68B shares derived: sum of 2 quarters · filed 2025-03-31 | -1.68B shares derived: sum of 3 quarters · filed 2025-03-31 | -1.68B shares derived: sum of 4 quarters · filed 2025-03-31 | ||
| 2023-12-31 | -1.68B shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -1.68B shares derived: sum of 2 quarters · filed 2025-03-31 | -1.68B shares derived: sum of 3 quarters · filed 2025-03-31 | 22.47K shares 10-K · filed 2025-03-31 | 1.69B shares 10-K · filed 2024-03-18 | |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2023-11-13 | 1.69B shares 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-11 | 1.69B shares 10-Q · filed 2023-08-11 | ||||
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-15 | |||||
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 0.00 shares 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-11 | |||||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-12 | 0.00 shares derived: sum of 3 quarters · filed 2019-03-12 | 0.00 shares 10-K · filed 2019-03-12 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2018-11-14 | 0.00 shares 10-Q · filed 2018-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 0.00 shares 10-Q · filed 2018-08-14 | 0.00 shares derived: sum of 3 quarters · filed 2018-08-14 | |||
| 2018-03-31 | 0.00 shares 10-Q · filed 2018-05-03 | 0.00 shares derived: sum of 2 quarters · filed 2018-05-03 | ||||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 20.00K shares 10-K · filed 2018-03-01 | ||||
| 2017-09-30 | 20.00K shares 10-Q · filed 2017-11-09 | |||||
| 2017-08-15 | 20.00K shares 10-K · filed 2021-03-31 |